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ABSTRACT: The first stage of the action mechanism of small cationic
peptides with antimicrobial activity is ruled by electrostatic interactions
between the peptide and the pathogen cell membrane. Thus, an increase in its
activity could be expected with an increase in the positive charge on the
peptide. By contrast, the opposite behavior has been observed when the charge
increases to reach a critical value, beyond which the activity falls. This work
studies the perturbation effects in a cell membrane model for two small
cationic peptides with similar length and morphology but with different
cationic charges. The synthesis and antibacterial activity of the two peptides
used in this study are described. The thermodynamic study associated with the
insertion of these peptides into the membrane and the perturbing effects on
the bilayer structure provide valuable insights into the molecular action
mechanism associated with the charge of these small cationic peptides.
■ INTRODUCTION
Over many years, antibiotics have proved essential for the
therapeutical treatments of different pathogen infections.
However, the increase in microbial resistance to antibiotics
due to their excessive use during recent decades means that
new therapeutical strategies are necessary. In this context, the
World Health Organization (WHO) issued a public health
warning in 2014, which states that this is not a problem that
humanity will have to face in the future but is something that is
happening today in the treatment of certain infections resistant
to conventional antibiotics. In this context, the increasing
incidence of microbial infections resistant to antibiotics is one
of the greatest challenges that modern medicine faces today.1
In this regard, a great number of cationic peptides that are
the first natural barrier against external pathogens have been
discovered and characterized. These cationic peptides can be
found in mammals, insects, plants, and the skins of some
amphibians.1−10 The two main characteristics of these cationic
peptides are that they have positive charges, ranging from +2 to
+9, and that they fold in an amphipathic helical conformation,
with two well-defined hydrophilic and hydrophobic faces.1,11,12
Although the alpha conformation is the most common,13 it has
been reported that cationic peptides with β-sheet conformation
can also show antibacterial activity.5,11,14
The main limitation for developing these cationic peptides as
the therapeutic agent is the lack of detailed knowledge about
their action mechanism at the molecular level.15 To help
remedy to this situation, our research group has contributed to
this topic with two publications. The first one provided insights
at the molecular level into the different mechanical properties
of binary lipid bilayers of dipalmitoyl phosphatidyl choline
(DPPC)/dipalmitoyl phosphatidyl serine (DPPS) in the
absence and presence of salt,16 and the second one suggested
an action mechanism for small cationic peptides with
antimicrobial and antifungal activity based on a study of the
mechanical and thermodynamic properties of binary lipid
bilayers of DPPC + DPPS.17
In line with the action mechanism of these antimicrobial
peptides,18 there is a wide consensus that these peptides focus
their target on the destabilization of the cell membrane of
Gram-negative and Gram-positive bacteria and fun-
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gus.1,7,11,14,19,20 Thus, these peptides exert their lytic activity
against pathogens by electrostatic interactions with the negative
charge of the microbial cell surfaces (favored by the positive
charge of these cationic peptides) and subsequent pathogen
membrane disruption.5,7,11,21 Hence, the positive charge of the
cationic peptide seems to be a crucial aspect that needs to be
considered in the discrimination process between the pathogen
and host cells.
In this context, the positive charge of these peptides, together
with the amphipathic nature of their alpha helical conformation,
seems to be key aspects for their antimicrobial activity.12,20
However, as reported elsewhere,14 the number of positive
charges of these peptides is a critical parameter in their
antimicrobial activity. Generally, an increase in the positive
charge enhances the antimicrobial activity of these cationic
peptides, although for a number of positive charges above +9
the antimicrobial activity almost disappears.1,22
Hence, the development of novel therapeutic agents that
could overcome the resistance to standard antibiotics seems to
be crucial for continuing the fight against disease. Among novel
treatments, small cationic peptides have shown a great potential
as a new generation of antibiotics.1,23 Increased knowledge of
the nature and action mechanism of natural cationic peptides
has enabled new synthetic peptides to be produced and tested
in clinical trials.24,25 These synthetic peptides (with antimicro-
bial activity) have shown activity when they were used in
animals as models of infections by a variety of pathogens.12,23,26
However, despite the great expectations in this field, clinical
trials have been limited, and none has been approved for use in
humans to date. Instead, trials have been limited to topical
applications26 because peptides that apparently have negligible
lethality and toxicity for mammalian cells in vitro have
frequently been found to be toxic when they were injected
into the bloodstream.25 Another important aspect related to
this delay in the use of such peptides in clinical trials is their
high cost of manufacture and, hence, of prescription drugs.27
To overcome all the inconveniences associated with the use of
these cationic peptides as new antibiotics, new short-chain
peptides, which have less than 12 residues and are cheaper to
manufacture, have been synthesized as candidates for use in
clinical trials. Our research group has previously reported new
small peptides (sequences possessing 11 and 12 amino acids)
with significant antibacterial activity.28 More recently, we
reported on a peptide with nine amino acids (Arg-Gln-Ile-
Arg-Arg-Ile-Ile-Gln-Arg-NH2) that had a strong antibacterial
effect against a panel of pathogenic bacteria;29 in fact, this
compound is the smallest peptide with the strongest
antibacterial activity reported to date.
The molecular dynamics (MD) simulation technique has
been accepted as a valuable complementary tool in
experimental studies to understand complex systems. In this
work, we focus on studying the effect of these cationic peptides
on the structure of a cell membrane model to predict their
antimicrobial activity. With this goal, a detailed study was
carried out with two small cationic peptides, RQWRRWWQR-
NH2 and RKFRRKFKK-NH2 with charges +4 and +7,
respectively, which are henceforth called pep+4 and pep+7, in
which the N-terminal amines were not considered for the
charge of these peptides. In the first step, the two peptides were
synthesized, and their antimicrobial activity was tested. In the
second step, the activity of these peptides was associated with
the level of perturbation of a phospholipid bilayer of DPPC in
the presence of different concentrations of the peptide
adsorbed on its surface. The reason why a zwitterionic
membrane was chosen as the cell membrane model instead
of a negatively charged one (which could be associated with a
pathogen cell membrane) is that (as was described recently in
the dynamic action mechanism of antimicrobial peptides17) the
activity of these peptides arises from the induction of
phospholipid domains in the pathogen membrane, and the
subsequent insertion of the peptides into the rich domains of
zwitterionic phospholipids, when the peptide reaches a certain
concentration on the outer cell membrane.
This work also studies the thermodynamic process associated
with insertion of the peptide into the membrane and how the
architecture of the cell membrane is perturbed in the presence
of cationic peptides of different charges.
■ RESULTS
Antibacterial Activity. Two peptides were chosen, whose
structural characteristics it was thought, would give different
activities and allow their molecular behavior to be evaluated
when they interact with the biological membrane.
We previously reported that pep+4 possesses a significant
antifungal activity against Candida albicans and Cryptococcus
neoformans,30 whereas pep+7 does not have any effect in this
respect.31 However, the antibacterial activity of both peptides
has not been evaluated to date. It should be noted that in both
cases, amphipathic α-helical conformation has been reported to
be the most favorable. Thus, in the first step of the study, and as
a preliminary analysis, the Edmundson wheels obtained for
these two peptides were evaluated (see Figure 1). From this
figure, it is evident that pep+4 has two perfect differentiated
faces of a similar size: a cationic face (marked with blue cut
lines) and a most hydrophobic face (represented by solid
yellow lines). The first face identifies residues R4, Q8, R1, R5,
and R9, accounting for the mutual Coulombic binding. These
residues are located on the same side of the helical peptide,
which was therefore designated the charged face. These
positively charged residues are able to interact with the
hydrophilic part of the lipids. The noncharged face is formed by
three hydrophobic (W6, W3, and W7) residues and one polar
(Q2) residue. This type of distribution has been proposed as an
essential structural characteristic for this type of peptide to
present antibacterial28 and antifungal31 activity. By contrast, pep
+7 (Figure 1) has a large cationic face covering most of the
Edmundson representation where all the cationic residues are
concentrated (R4, K8, R1, R5, K9, K2, and K6) and only a
Figure 1. Edmundson representation obtained for the two peptides,
pep+4 and pep+7.
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small hydrophobic portion formed by F3 and F7. This is a
striking difference with respect to pep+4.
To make a more accurate evaluation of the differential
structural characteristics of these two peptides, in a second
stage of the study an electronic analysis of these compounds
was performed by analyzing their molecular electrostatic
potentials (MEPs).32 Molecular electrostatic fields and MEPs
provide a relevant description of the capacity of peptides to
generate stereoelectrostatic forces. More positive potentials
reflect nucleus predominance, while less positive values
represent rearrangements of electronic charges and lone pair
of electrons. The MEPs of peptides pep+4 and pep+7 are
shown in Figure 2. To better appreciate the electronic behavior
of pep+4 and considering that two different faces were signaled
in Figure 1, we present the MEPs of pep+4 and pep+7, showing
the two faces. Figure 2a shows the charged face of pep+7, which
is characterized by the presence of seven cationic residues (R-1,
K-8, R-5, K-9, K-6, K-2, and R-4). It is clear from the figure that
blue color shows the extended moiety of pep+7. In turn, Figure
2b shows the small portion of the hydrophobic zone of pep+7
characterized by only two residues, F-3 and F7.
As expected, significant differences can be seen in the
electronic distributions of pep+4 with respect to pep+7
(compare Figure 2a,b with 2c,d). Pep+4 shows two well-
differentiated but similar-sized portions. Its cationic face is
characterized by the four cationic residues (R4, R1, R5, and R9)
and one polar residue (Q8), while the hydrophobic face is
formed by three hydrophobic amino acids (W6, W3, and W7)
and one polar residue (Q2). It has been previously reported
that peptide and lipid association occurs through the formation
of salt bridges between the positively charged residues and the
lipid phosphate groups.33 In addition, tryptophan fluorescence
studies have previously shown the importance of positively
charged residues for the initial binding of these small peptides
to negatively charged vesicles because double R/K/A mutations
significantly decreased the binding affinity.34 The MEPs of pep
+4 suggest that the above-mentioned residues (R1, R4, R5, and
R9) could be responsible for the initial binding in pep+4.
It has been reported that the mutation of strategically located
tryptophan residues decreases internalization, whereas double
substitution completely inhibits peptide internalization.35−37 It
appears that charge neutralization is required for the peptide to
insert itself deeply into the hydrophobic core of the membrane.
A significant hydrophobic face appears to be important in this
sense. On the basis of our results, it is reasonable to expect that
pep+4 could present antibacterial activity because, despite its
small size, it meets the previously established structural
requirements for the active peptides. In contrast, pep+7 should
not possess any antibacterial effect. After obtaining the
stereoelectronic characteristic of the two peptides, our next
step was to evaluate their antibacterial activity. As expected, pep
+4 showed a significant antibacterial activity against a panel of
pathogenic bacteria, whereas pep+7 had no antibacterial effect.
In the next sections, we present and discuss the results of
extensive MD simulations to explain at the molecular level the
influence of charge on the antibacterial activity of these small
peptides.
Peptide Distribution. Figure 3 shows the peptide
distribution function for both types of peptides studied in
this work, corresponding to pep+4 and pep+7, after 100 ns of
simulation time. In both figures, it can be seen how pep+4 is
distributed on both leaflets of the bilayer, even though both
peptides were placed near the same leaflet, as can be seen in
Figure 4.
Figure 3 shows that the peptide concentration of pep+4
adsorbed on the membrane increases almost linearly with the
number of peptides added to the system. This behavior permits
a certain peptide threshold concentration to be reached on the
membrane surface that is sufficient to induce the disruption of
the bilayer structure, as was discussed elsewhere.17 By contrast,
an increase in the pep+7 concentration is not reflected in an
increase in the peptide concentration on the surface, making it
almost impossible to reach a threshold concentration that can
perturb the membrane structure, that is, to show antimicrobial
Figure 2. Electrostatic potential-encoded electron density surfaces of
the structures of peptides pep+4 (c,d) and pep+7 (a,b). The coloring
represents electrostatic potential with red indicating the strongest
attraction to a positive point charge and blue indicating the strongest
repulsion. The electrostatic potential is the energy of interaction of the
positive point charge with the nuclei and electrons of a molecule. It
provides a representative measure of overall molecular charge
distribution.
Figure 3. Peptide and DPPC phosphorous (P) distribution after 100
ns of simulation time. Left column corresponds to pep+4 and right
column to pep+7. Labels (a−c) refer to peptide/phospholipid ratios of
1/32, 1/16, and 1/8, respectively.
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activity. The migration of pep+7 in Figure 3 from one leaflet to
the other is clearly associated with the electrostatic repulsions
between neighboring peptides because of a poor charge
screening between them, as a consequence of their low ability
to penetrate into the bilayer compared with the behavior shown
by pep+4. We remark that this migration of pep+7 from one
side to the other of the lipid bilayer takes place through the
water layer associated with the periodicity of the computational
box and never across the lipid bilayer.
Order Parameter, SCD, and Surface Area per Lipid
Molecule. The order parameter, SCD, provides information
about the disorder in the hydrocarbon region inside the lipid
bilayer, a property that can be determined experimentally from
2H NMR splittings. Thus, from the values of quadrupolar
splittings, ΔνQ, obtained from 2H NMR, the deuterium order
parameter, SCD, can be calculated as follows
νΔ = ⟨ ⟩C S3
2Q
CD
(1)
where C is the quadrupole coupling constant (C = 170 kHz38)
and SCD is the order parameter of a given C−D bond.
Furthermore, the order parameter can be extracted directly
from simulations using
ϕ⟨ ⟩ = ⟨ − ⟩S 3 cos 1
2CD
2
(2)
Here, ϕ is the angle between the C−D bond and the bilayer
normal and the average is obtained over the simulation time
and the number of identical molecules in the computational
box. However, bearing in mind that hydrogens from methylene
groups are not explicitly considered in DPPC in our
simulations, the order parameter corresponding to a given
C−D bond can be calculated using a methodology described
elsewhere.39
Figure 5 shows how the presence of pep+7 does not perturb
the hydrocarbon structure in the interior of the phospholipid
bilayer throughout the range of concentrations studied in this
work. This behavior contrasts with that measured in the
presence of pep+4, in which, for a given peptide concentration
above a threshold value, a noticeable increase in the
phospholipid disorder is measured as the peptide concentration
increases.
Furthermore, Table 1 shows the surface area per lipid
molecule for different peptide/lipid ratios in our simulations
and also shows how the presence of pep+7 produces a
shrinkage in the surface area per phospholipid with respect to
its value in the absence of peptides in solution. This result
contrasts with those obtained in the presence of pep+4, in
which the lipid surface was seen to expand. These results
closely agree with the results obtained from the deuterium
order parameter (see Figure 5), in which an increase in the
disorder of the hydrocarbon region with the P/L ratio was
measured, which was associated with an increase in the free
space between adjacent phospholipids, as it would be expected
from an increase in the surface area per lipid molecule.
Thickness of the Lipid Bilayer. To estimate the effect of
the presence of cationic peptides on the thickness of the lipid
bilayer, Figure 6 depicts the phosphorus distribution on both
lipid leaflets that form the lipid bilayer, in the presence and
absence of cationic peptides.
Figure 6 shows how the presence of pep+7 was no affected
on the thickness of the lipid bilayer at any concentration. This
result contrasts with those obtained for pep+4, where for a
given threshold concentration a reduction of 20% in the
thickness of the lipid bilayer was evident.
Figure 4. Snapshot of the starting configuration of DPPC bilayers in
the presence of the two peptides studied in this work. In both cases,
the peptides were placed near one leaflet of the lipid bilayer. (Up)
DPPC in the presence of 40 pep+4 (yellow) and (down) DPPC in the
presence of 40 pep+7 (red). Blue beads correspond to chloride ions
used to balance the total charge existing in the system. Water has been
removed for clarity. Figure 5. Simulated deuterium order parametersSCD along the
DPPC hydrocarbon tail of a DPPC bilayer, for different peptide/
phospholipid ratios, (a) pep+4 and (b) pep+7. Circles correspond to
the experimental data of a DPPC bilayer in the absence of peptides at
350 K.40
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Bending Modulus, kb, of the Lipid Bilayer. The bending
modulus, kb, is calculated as follows
ξ=k K
24
b A
2
(3)
where KA corresponds to the compressibility modulus of the
membrane and ξ the effective thickness of the lipid bilayer,
calculated as ξ = dP−P − 1, where dP−P is the distance between
the maximum of phosphorus distribution of both lipid leaflets
that form the lipid bilayer. KA is calculated as follows
σ
=K k TA
A( )A
B
2 (4)
where kB is the Boltzmann constant, T the temperature, A the
surface area per lipid molecule, and σ2(A) the mean square
fluctuation of the interfacial area.
Table 2 shows the bending modulus of the different systems
studied in this work. In the absence of peptides, a kb value of 29
kBT was measured for the lipid DPPC bilayer. This value agrees
with the experimental data obtained from pipette aspiration41,42
and neutron spin echo43 measurements, which gave values of kb
in a range of 11−30 kBT, depending on the length of the lipid
hydrocarbon tails and temperature.
In the presence of pep+7, kb remains almost unaltered over
the whole range of concentrations studied as a consequence of
the poor interactions between the peptides and the lipid bilayer,
as discussed above. By contrast, in the presence of pep+4, kb
increased as the number of peptides adsorbed on the surface of
the lipid bilayer increased as well, until a given threshold
concentration was reached, corresponding to a peptide/lipid
ratio of 1/8, when kb is 25% lower than that of the value of the
lipid bilayer in the absence of peptides. This sharp decrease in
the bending modulus of the lipid bilayer (i.e., an increase in its
flexibility) gives an idea of how the mechanical properties of the
lipid membrane are disrupted, as a prelude of the lytic activity
of these cationic peptides.
Lateral Pressure, π(z). The lateral pressure profile across a
lipid bilayer, π(z), is a key aspect related with its mechanical
stability. Computationally, the lateral pressure profile can be
estimated using the algorithm of Lindhal and Edholm,44 where
a detailed description of how this property is calculated can be
found elsewhere.17
In this regard, Figure 7 shows the lateral pressure profile,
π(z), for the DPPC bilayer in the absence and presence of
peptides adsorbed on the membrane.
Unfortunately, there is not an experimental verification of
this property, although the results obtained in our simulations
are in a reasonable agreement with the results provided by
Kamo et al.45 from fluorescence measurements, in which a
lateral pressure of 350 atm was estimated in the middle of a
lipid bilayer.
Figure 7 shows how the pressure profile is not perturbed by
the presence of pep+7 in comparison with the case in which
pep+4 is present, showing the existence of a threshold
concentration from which a noticeable perturbation of the
bilayer stability takes place. In this regard, and on the basis that
an increase in the pressure is associated with an increase in the
Table 1. Surface Area of DPPC for Different Peptide/Phospholipid Ratios of Peptides Adsorbed on the Lipid Bilayer
peptide/DPPC ratio
peptide without peptides 1/32 1/16 1/8
pep+7 0.698 ± 0.004 0.664 ± 0.005 0.659 ± 0.004 0.672 ± 0.005
pep+4 0.698 ± 0.004 0.673 ± 0.003 0.682 ± 0.003 0.719 ± 0.006
Figure 6. Phosphorous distribution across the lipid bilayer for different
peptide/phospholipid ratios in the presence of pep+4 (a) and pep+7
(b).
Table 2. Bending Modulus, kb, of the DPPC Bilayers for
Different Peptide/phospholipid Ratiosa
kb/(kBT)
peptide/lipid ratio
peptide without peptides 1/32 1/16 1/8
Pep-7 29 28.3 32 30
Pep-4 29 36 48 22
akB corresponds to the Boltzmann constant and T the temperature.
Figure 7. Lateral pressure π(z) of the DPPC bilayer in the absence
and presence of peptides for different peptide/phospholipid ratios. (a)
Corresponds to pep+4 and (b) to pep+7.
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instability of the bilayer architecture, this behavior is in good
agreement with the higher antimicrobial activity of pep+4 than
pep+7, in spite of its high positive charge. However, in both
cases, the main perturbation takes place in the vicinity of the
phospholipid/water interface, in line with the discussion
described above.
Thermodynamic Study of Peptide Insertion in the
Lipid Bilayer. Free Energy Associated with Peptide Insertion
into the Lipid Bilayer. The partition function of a certain
species between two mediums is directly related with the
difference of free energy associated with this process, as follows
Δ = −
*
G z RT
C z
C
( ) ln
( )
(5)
where C(z) corresponds to the species concentration at a
certain position z perpendicular to the interface and C* its
concentration in the bulk solution. To estimate the potential
mean force (PMF) associated with the insertion of peptides
into a lipid bilayer, two peptides were considered simulta-
neously in our simulations, and the Umbrella46 and WHAM47
were the computational methods used to estimate the PMF.
Thus, we placed one of the two peptides in bulk water and the
other in the middle of the lipid bilayer formed by 288 DPPC
(144 DPPC per leaflet) and 17 516 water molecules with their
corresponding Cl− to balance the charges of the system. Hence,
starting from this first conformation, peptides were displaced
along the Z-axis to estimate the PMF across the lipid bilayer.17
Figure 8 shows ΔG(z) corresponding to the insertion into
the DPPC bilayer of the two cationic peptides studied in this
work. From Figure 8, it can be seen how the adsorption of
peptides into a lipid bilayer is a spontaneous process for both
peptides, which corresponds to the negative values of ΔG(z).
However, this process is −37 kJ/mol lower for pep+7 than for
pep+4, as a consequence of the strong electrostatic interactions
between peptide/lipid bilayers. On the other hand, a
thermodynamic barrier to the insertion of these peptides into
the bilayer emerged, which is 39 kJ/mol higher for pep+7 than
for pep+4. This difference may be associated with the existence
of tryptophan residues in pep+4 but not in pep+7, and hence,
its insertion into the hydrocarbon region of the lipid bilayer is
favored. Hence, from this thermodynamic study, we conclude
that the insertion of pep+4 into the core of the hydrocarbon
region of the lipid bilayer is easier than it is for pep+7, which
could explain its antibacterial activity. For its part, pep+7
cannot penetrate into the membrane to disrupt the membrane
structure and hence perturbs the mechanical properties of the
lipid membrane to provide lytic activity, remaining anchored to
the surface of the lipid bilayer.
Enthalpy and Entropy of the Peptide Insertion. Obtaining
thermodynamic information related to peptide insertion into
the lipid bilayer is of crucial importance in order to understand
the thermodynamic driving force that rules the interaction of
these small cationic peptides with a lipid membrane.
In this regard, from classical thermodynamics, it is known
that entropy ΔS, enthalpy ΔH, and the free energy ΔG are
related by the well-known expression
Δ = Δ − ΔG H T S (6)
where ΔH and ΔS correspond to the variation of enthalpy
(energy) and entropy (disorder) involved with this thermody-
namic process.
According to classical thermodynamics, the variation of
entropy associated with a given thermodynamic process can be
calculated from the variation in free energy at two different
temperatures, as follows
Δ = −Δ⎜ ⎟⎛⎝
⎞
⎠
G
T
S
d
d P (7)
A solution to this differential equation can be approximated
numerically as follows
− Δ = Δ
≃
Δ
Δ + Δ − Δ − Δ
⎜ ⎟⎛⎝
⎞
⎠S
G
T
T
G T T G T T
d
d
1
2
( ( ) ( ))
P
(8)
Thus, from the free-energy profile of ΔG at two different
temperatures, the entropy of peptide insertion into a
phospholipid bilayer can be estimated. Once ΔS has been
calculated, the enthalpic contribution to the free energy can
also be estimated, using eq 6. In our case, two additional
profiles of free energy corresponding to 340 and 360 K were
obtained. Figure 9 shows the free energy (ΔG), enthalpy (ΔH),
and entropy (ΔS) profiles associated with the insertion of pep
+4 and pep+7 to the lipid bilayer at 350 K.
Figure 8. (a) Free-energy profile associated with the insertion of
cationic peptides into a DPPC bilayer. (b) Atomic phosphorous
distribution across the DPPC bilayer.
Figure 9. ΔG, ΔH, and ΔS associated with the insertion of pep+4 and
pep+7 into a DPPC bilayer.
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With regard to pep+4, we observe how ΔH is negative
(exothermic process) in the vicinity of the lipid/water interface
with a value of −194 kJ/mol (or −46.4 kcal/mol) and becomes
positive (endothermic) in the middle of the lipid bilayer, with a
value of 189 kJ/mol (or 45 kcal/mol). The binding enthalpy of
pep+4 to the lipid bilayer is a reasonable good agreement with
the values of −14.4 and −17.0 kcal/mol measured by
isothermal titration calorimetry of pexiganan48 and magainin-
2 bound to vesicles,26,48,49 once the difference in size and
charge between these species has been discounted. With regard
to the variation of entropy, there was a decrease at the vicinity
of the bilayer/water interface (as expected for strong
electrostatic interactions with the polar head of lipids at the
lipid/water interface), followed by an increase toward the
aliphatic region inside the bilayer. Thus, from the analysis of
ΔH and ΔS, it is concluded that insertion into the lipid bilayer
is governed by an increase in the entropic contribution to the
free energy inside of the lipid bilayer.
In the case of pep+7, ΔH presents a minimum of −139 kJ/
mol in the vicinity of the lipid bilayer (or −33 kcal/mol), a
value that is also in reasonable agreement with the values of ΔH
for pexiganan and magainin-2 bound to vesicles, as mentioned
above. It is important to note that unlike pep+4, ΔH follows
the same trend as ΔG, as a consequence of the almost null
contribution of the entropy to the free energy. This means that
the free energy is mainly dominated by its energetic term, ΔH,
while the contribution of the entropy to the free energy is very
low. This low contribution of the entropy is associated with the
strong electrostatic interactions between the peptides and the
polar heads of phospholipids, which dramatically reduces the
mobility of these peptides at the bilayer/solution interface, in
perfect agreement with the results obtained by simulation.
This interpretation is based on the results concerning the
disorder of lipid bilayers in the presence of peptides. Thus, in
the presence of pep+4, a decrease in the order parameters (an
increase in the disorder in the hydrocarbon region of the lipids)
of phospholipids was measured, unlike in the case of pep+7, in
which the order parameters of the phospholipids remained
constant over the whole range of peptide concentrations
studied in this work.
From the analysis and comparison of ΔG, ΔH, and ΔS for
both peptides, we conclude that an excess of charge reduces the
disorder inside the lipid bilayer associated with the presence of
these peptides, that is, the possibility of disrupting the lipid
bilayer structure decreases. Hence, the results suggest that
entropy is the key property that must be investigated to predict
the antimicrobial activity of these small cationic peptides.
■ CONCLUSIONS
There are many theoretical and experimental studies that have
focused on the influence of charge on the antibacterial activity
of these small peptides. In this sense, it is known that to achieve
a certain level of antimicrobial activity, the charge of these
cationic peptides must be between +2 and +9 (depending on
the size of the peptide). The results presented in this work are
the first to provide an explanation (at the molecular level) of
why charged peptides are not able to reach the threshold
concentration necessary to produce the deformation of the
membrane, that is, its subsequent biological activity.
To increase our knowledge of the role played by the charge
in the antimicrobial activity of new synthetic peptides, two
peptides with charges +4 and +7 were studied. From in vitro
studies, it was demonstrated how the peptide with charge +7
does not show antimicrobial activity, whereas the peptides with
charge +4 do.
From the thermodynamic study of peptide insertion into a
phospholipid bilayer of DPPC, and evaluation of the bilayer
structure in the absence and presence of a peptide, it has been
shown how a peptide with charge +7 does not reach the
threshold concentration necessary to induce membrane
disruption. This behavior seems to be associated with the fact
that poor insertion into the lipid bilayer cannot screen out the
electrostatic repulsion between peptides, and there is mutual
repulsion between neighboring peptides, resulting in a low
concentration of peptides adsorbed on the lipid bilayer. This
behavior contrasts with that obtained for the peptide with
charge +4, whose tendency to protrude into the lipid bilayer
reduces the electrostatic repulsions between neighboring
peptides. This behavior permits a threshold concentration
that is sufficient to induce the disruption of the membrane, that
is, its lytic activity.
Finally, a thermodynamic study of the peptide insertion into
the lipid bilayer points to the entropy being the key property
that links the charge/structure of these peptides with their lytic
activity.
■ MODEL AND METHODS
Antimicrobial Peptides. Two different peptides were used
as models in the study with primary structures
RQWRRWWQR-NH2 (pep+4) and RKFRRKFKK-NH2 (pep
+7), with charges +4 and +7, respectively. General information
about the synthesis of both peptides is given below, and for
more details, see refs 30 and 31.
Peptide Synthesis and Antibacterial Activity. The
synthesis of both peptides described above was carried out in
a solid phase, following the experimental procedure described
elsewhere.30 The microorganism used to determine their
antibacterial activity was provided by the laboratorio de
Microbiologia, Facultad de Ciencias Medicas, Universidad
Nacional de Cuyo, Mendoza, Argentina, Laboratorio de
Microbiologia, Hospital Marcial Quiroga, San Juan, Argentina,
and Pasteur Institute. Furthermore, the minimal inhibitory
concentrations of these peptides were determined using the
broth microdilution method following the methodology
described elsewhere,29 in which all the assays were carried
out in triplicate.
Cell Membrane Model. A zwitterionic phospholipid
bilayer of DPPC composed of 648 DPPC molecules (324 per
leaflet) and 28 526 water molecules of the single point charge
(SPC)50 was considered as the cell membrane model in our
simulations. The reason for choosing a zwitterionic bilayer for
the simulations is based on the previous results obtained for the
dynamics action mechanism.17 This work17 demonstrated how
small cationic peptides induce phospholipid segregations of
lipid domains, prior to showing lytic activity, when they reach a
threshold concentration on the surface of the cell membrane
and then penetrate into the membrane of those domains that
are rich in zwitterionic phospholipids.
MD Simulations. GROMACS 4.5.351,52 was the package
used to carry out the MD simulations. All the simulations were
performed in NPT conditions, using the algorithm proposed by
Berendsen,53 with coupling constants of 0.1 and 1 ps for
temperature and pressure, respectively. The temperature of all
our simulations was 350 K, which is above the transition
temperature of 314 K of DPPC bilayers.38 The long-range
interactions were simulated using the Lennard-Jones potential,
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and the electrostatic interactions were calculated using the
particle mesh Ewald method54,55 with a cutoff of 1 nm. The
molecular bonds were restrained using LINCS algorithm.56 The
SPC water model50 was considered in all our simulations.
A trajectory length of 200 ns was simulated in all the cases
studied in this work. The force field used in this work was the
same as that described in a previous work17 using the
GROMOS 54A7 force field57 implemented in the GROMACS
package.
Molecular Electrostatic Potentials. Quantum mechanics
calculations were carried out using the Gaussian 09 program,58
and the most populated conformations of peptides one and two
were obtained from MD simulations. Subsequently, single point
density functional theory (DFT) calculations were carried out.
Correlation effects were included using DFT with the Becke-3−
Lee−Yang−Parr (RB3LYP)59,60 functional and 6-31++G(d,p)
basis set for all the complexes. During the DFT calculations, the
geometries were kept fixed. The electronic study was carried
out using MEPs.32 Graphical presentations were created using
the MOLEKEL program 2.3.3 MEPs.
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